Isn’t it about time that CDRH is renamed the Center for Medical Technology?
The U.S. Food and Drug Administration has proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices and announced the first submission: a brain-controlled, upper-extremity prosthetic that will serve as a pilot for the program. The FDA also announced plans to seek further public comment before the Pathway can be used more broadly.
For the complete FDA announcement, see here.
"We do what we must, and call it by the best names."
-- Ralph Waldo Emerson
